Taro Pharmaceutical Industries Overview

Taro Pharmaceutical Industries Operating Income

Operating Income for TARO.

Quarterly Operating Income

$8.78M

↓ 5.28% YoY

As of Mar 31, 2024

Annual Operating Income (TTM)

$21.48M

↑ 4.79% YoY

Trailing 12 months ending Mar 31, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin